Successful Execution of Clinical Trials in Emerging Markets: Operational Best Practices for Clinical Data Capture
Presented by industry leading strategists Dwight Cooper and Mark Wade.
As global regulatory agencies place more emphasis on the voice of the patient, sponsors and CROs need to capture patient reported outcomes (PROs) from a widening range of global communities. Regardless of where the PROs are collected, the data will be audited for accuracy and admissibility.
Capturing patient data electronically instead of on paper provides valid data more reliably and efficiently; yet emerging markets demand even greater expertise. PHT is the leading expert in collecting electronic patient reported outcomes (ePROs), having conducted over 400 trials in 85 languages, in 64 countries.
Translating PROs is a challenging task given the exponential growth of clinical trials in emerging markets. Lionbridge Life Sciences is a leading provider of high-quality translation, linguistic validation, and interpretation services to pharmaceutical companies and CROs in over 150 languages.
By attending this joint PHT/Lionbridge Life Sciences presentation, you will:
- Understand the logistical issues involved in collecting clinical trial data using multiple modalities in emerging markets
- Hear case studies featuring recent Phase III trials conducted in more than 20+ languages and countries
- Appreciate the complex role translation plays in clinical trials, particularly in emerging markets
Click here to watch this webinar replay